Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response
|
|||||
Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins. . . . → Read More: Clinical Trial Begins for Peanut Allergy Treatment A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis. . . . → Read More: Lab to Develop New Bio-Based Sustainable Materials A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects. . . . → Read More: Safer Forms of Psilocybin Assessed in Preclinical Study A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I. A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications. . . . → Read More: Quantum Technology Start-Up Accelerator Unveiled Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round. . . . → Read More: Biotech to Design Disease-Blocking Drugs, Gains $75M |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |